Karen Coffman

1.2k citations

15 papers · 970 indexed · h-index 12

Molecular Biology
Cellular and Molecular Neuroscience top 5%
Oncology top 10%
Cell Biology top 5%
Pulmonary and Respiratory Medicine

Co-authors: Michael S. Kinch Elizabeth Bruckheimer David G. Bostwick Jennifer Walker‐Daniels J. S. Rhim Paul W. Snyder B. J. Kerns David J. Waters
Topics: Axon Guidance and Neuronal Signaling (6 papers)Angiogenesis and VEGF in Cancer (5 papers)HER2/EGFR in Cancer Research (3 papers)
Cited by: Cellular and Molecular Neuroscience Cell Biology Oncology
Journals: Journal of Clinical Investigation Journal of Clinical Oncology JNCI Journal of the National Cancer Institute
Partner nations: United States Japan Sweden

In The Last Decade

Karen Coffman

15 papers receiving 950 citations

Peers

Countries citing papers authored by Karen Coffman

Since Specialization

Citations

This map shows the geographic impact of Karen Coffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Coffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Coffman more than expected).

Fields of papers citing papers by Karen Coffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Coffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Coffman. The network helps show where Karen Coffman may publish in the future.

Co-authorship network of co-authors of Karen Coffman

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Coffman. A scholar is included among the top collaborators of Karen Coffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Coffman. Karen Coffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC 2022 ·JCI Insight ·Eric Tu,Kelly McGlinchey,Jixin Wang,Philip Martin,(unknown),Nicolas Floc’h,(unknown),Jacqueline H. Starrett,(unknown),Leslie Wetzel,Barrett Nuttall,Felicia Ng,Karen Coffman,Paul D. Smith,Katerina Politi,Zachary A. Cooper,Katie Streicher	75
2	Abstract 911: Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR mutant NSCLC 2020 ·Cancer Research ·Eric Tu,Kelly McGlinchey,(unknown),(unknown),Susan Wilson,Leslie Wetzel,Karen Coffman,Zachary A. Cooper,Katie Streicher	1
3	Increased CD73 and reduced IFNG signature expression in relation to response rates to anti-PD-1(L1) therapies in EGFR-mutant NSCLC. 2017 ·Journal of Clinical Oncology ·Katie Streicher,Brandon W. Higgs,Song Wu,Karen Coffman,Gautam Damera,(unknown),Lydia Greenlees,(unknown),Cheng Li,Zachary A. Cooper,Koustubh Ranade	33
4	Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties 2016 ·mAbs ·Binyam Bezabeh,Ryan Fleming,Christine Fazenbaker,Haihong Zhong,Karen Coffman,Xiang‐Qing Yu,Ching Ching Leow,(unknown),Susan Wilson,C. Kendall Stover,Herren Wu,Changshou Gao,Nazzareno Dimasi	16
5	Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer 2010 ·Cancer Biology & Therapy ·William M. Merritt,Aparna A. Kamat,(unknown),Justin Bottsford-Miller,Chunhua Lu,Yvonne G. Lin,Donna Coffey,Whitney A. Spannuth,Elizabeth Nugent,Liz Y. Han,Charles N. Landen,Alpa M. Nick,Rebecca L. Stone,Karen Coffman,Elizabeth Bruckheimer,Russell R. Broaddus,David M. Gershenson,Robert L. Coleman,Anil K. Sood	49
6	Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors 2009 ·Neoplasia ·Elizabeth Bruckheimer,Christine Fazenbaker,Sandra Gallagher,Kathy Mulgrew,Stacy Fuhrmann,Karen Coffman,William D. Walsh,Shannon Ready,(unknown),Melissa Damschroder,Michael S. Kinch,Peter A. Kiener,Rob Woods,Changshou Gao,William F. Dall’Acqua,Herren Wu,Steven Coats	29
7	Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib 2009 ·Molecular Cancer Therapeutics ·Ching Ching Leow,Jon Chesebrough,Karen Coffman,Christine Fazenbaker,John Gooya,David Weng,Steve Coats,Dowdy Jackson,Bahija Jallal,Yong S. Chang	34
8	The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling 2008 ·Journal of Clinical Investigation ·Dana M. Brantley‐Sieders,Guanglei Zhuang,Donna J. Hicks,Wei Bin Fang,Yoonha Hwang,Justin Cates,Karen Coffman,Dowdy Jackson,Elizabeth Bruckheimer,Rebecca S. Muraoka-Cook,Jin Chen	223
9	Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer 2006 ·JNCI Journal of the National Cancer Institute ·Charles N. Landen,Chunhua Lu,Liz Y. Han,Karen Coffman,Elizabeth Bruckheimer,Jyotsnabaran Halder,Lingegowda S. Mangala,William M. Merritt,Yvonne G. Lin,(unknown),Rosemarie Schmandt,Aparna A. Kamat,Yang Li,Premal H. Thaker,David M. Gershenson,Nila U. Parikh,Gary E. Gallick,Michael S. Kinch,Anil K. Sood	99
10	Differential EphA2 epitope display on normal versus malignant cells. 2003 ·PubMed ·Karen Coffman,Min Hu,(unknown),David A. Tice,(unknown),(unknown),(unknown),Robert M. Woods,Solomon Langermann,Peter A. Kiener,Michael S. Kinch	78
11	The Role of Angiostatin in the Spontaneous Bone and Prostate Cancers of Pet Dogs 2002 ·Biochemical and Biophysical Research Communications ·Steven Pirie‐Shepherd,Karen Coffman,Donald Resnick,Roger W. Chan,O. Kisker,Judah Folkman,David J. Waters	5
12	Prostaglandin E2concentrations in naturally occurring canine cancer 2001 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Sulma I. Mohammed,Karen Coffman,Nita W. Glickman,Michael G. Hayek,David J. Waters,Deborah L. Schlittler,Dennis B. DeNicola,Deborah W. Knapp	58
13	Overexpression of the EphA2 tyrosine kinase in prostate cancer 1999 ·The Prostate ·Jennifer Walker‐Daniels,Karen Coffman,(unknown),J. S. Rhim,David G. Bostwick,Paul W. Snyder,B. J. Kerns,David J. Waters,Michael S. Kinch	231
14	Avidity of IgA Antibody to Escherichia coli Polysaccharide and Diphtheria Toxin in Breast Milk from Swedish and Pakistani Mothers 1988 ·Scandinavian Journal of Immunology ·Don Roberton,B. Carlsson,Karen Coffman,Mirjana Hahn‐Zoric,F Jalil,C. L. Jones,Lars Hanson	33
15	Mucosal immunity--from past to present. 1988 ·PubMed ·Hanson La,Ingegerd Adlerberth,(unknown),Karen Coffman,U. Dahlgren,K. Nilsson,F Jalil,D Roberton	6

About Karen Coffman

Karen Coffman is a scholar working on Cellular and Molecular Neuroscience, Oncology and Endocrinology, having authored 15 papers that have together received 970 indexed citations. Recurring topics across this work include Axon Guidance and Neuronal Signaling (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (478 citations), Cell Biology (246 citations) and Oncology (314 citations). Karen Coffman has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Michael S. Kinch, Elizabeth Bruckheimer, David G. Bostwick, Jennifer Walker‐Daniels, J. S. Rhim, Paul W. Snyder, B. J. Kerns, David J. Waters, Dowdy Jackson and Dana M. Brantley‐Sieders. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact